Loading...

Pacira BioSciences Reports Positive Topline Data From Phase 3 Study Of EXPAREL

RTTNews | 847 days ago

Pacira BioSciences Reports Positive Topline Data From Phase 3 Study Of EXPAREL

(RTTNews) - Pacira BioSciences, Inc. (PCRX) announced Wednesday positive topline results from its Phase 3 study of EXPAREL as a single-dose sciatic nerve block in the popliteal fossa for postsurgical regional analgesia in patients undergoing bunionectomy.

EXPAREL achieved the study's primary endpoint by demonstrating a statistically significant reduction in cumulative pain scores from 0 to 96 hours compared with bupivacaine HCl.

EXPAREL also achieved statistical significance for reduction in postsurgical opioid consumption and percentage of opioid-free subjects through 96 hours compared with bupivacaine HCl, which were key secondary endpoints. EXPAREL was well tolerated with a safety profile consistent with bupivacaine HCl.

Pacira plans to submit a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) early next year to expand the EXPAREL label to include sciatic nerve blocks in the popliteal fossa, as well as femoral nerve blocks in the adductor canal.

For More Such Health News, visit rttnews.com

Tags: PCRX

read more

Pacira BioSciences Appoints Frank Lee To Succeed David Stack As CEO

Pacira BioSciences Appoints Frank Lee To Succeed David Stack As CEO

Regenerative health provider Pacira BioSciences, Inc. (PCRX) announced Thursday that its Board of Directors has appointed Frank Lee as Chief Executive Officer and a member of the Board, effective January 2, 2024.

RTTNews | 391 days ago

Asian Shares Muted Ahead Of US CPI Data

Asian Shares Muted Ahead Of US CPI Data

Asian stocks ended little changed on Wednesday after reports emerged that U.S. President-elect Donald Trump's economic advisers are discussing slowly ramping up tariffs month by month.

RTTNews | 5h 17min ago

Pound Slides Against Majors

Pound Slides Against Majors

The British pound weakened against other major currencies in the pre-European session on Wednesday.

RTTNews | 5h 57min ago

Yen Rises As BoJ Governor Ueda Signals Rate Hike

Yen Rises As BoJ Governor Ueda Signals Rate Hike

The Japanese yen strengthened against other major currencies in the Asian session on Wednesday, after Bank of Japan Governor Kazuo Ueda signaled raising interest rates at next week's meeting.

RTTNews | 6h 40min ago

European Economic News Preview: UK Inflation Data Due

European Economic News Preview: UK Inflation Data Due

Consumer and producer prices from the UK and industrial production from the euro area are the top economic news due on Wednesday. At 2.00 am ET, the Office for National Statistics releases UK consumer and producer prices for December. Inflation is forecast to remain unchanged at 2.6 percent. Economists forecast output prices to remain flat on year, following a 0.6 percent drop in November.

RTTNews | 7h 13min ago

Yen Rises Against Majors

Yen Rises Against Majors

The Japanese yen strengthened against other major currencies in the Asian session on Wednesday.

RTTNews | 7h 22min ago

European Shares Seen Modestly Higher At Open; US CPI Data Eyed

European Shares Seen Modestly Higher At Open; US CPI Data Eyed

European stocks may see modest gains at open on Wednesday as investors await the U.S. consumer price index (CPI) report for December 2024 later in the day for clues on the path of Federal Reserve policy.

RTTNews | 8h 29min ago

Sensex, Nifty Modestly Higher Led By PSU Stocks; Financials Drift Lower

Sensex, Nifty Modestly Higher Led By PSU Stocks; Financials Drift Lower

Indian shares were slightly higher in early trade on Wednesday after bouncing back from a four-day losing streak the previous day on signs of easing retail inflation in the country.

RTTNews | 9h 16min ago

Terms | Privacy | Site Map | Site Map Calendar

© 2025 Myfxbook Ltd. All Rights Reserved.

HIGH RISK WARNING: Foreign exchange trading carries a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before you decide to trade foreign exchange, carefully consider your investment objectives, experience level, and risk tolerance. You could lose some or all of your initial investment. Do not invest money that you cannot afford to lose. Educate yourself on the risks associated with foreign exchange trading, and seek advice from an independent financial or tax advisor if you have any questions. Any data and information is provided 'as is' solely for informational purposes, and is not intended for trading purposes or advice. Past performance is not indicative of future results.